TuHURA Biosciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TuHURA Biosciences generated cash of -$11,950,856, which is less than the previous year. Cash used in financing activities reached the amount of $2,660,249 last year. Net change in cash is therefore -$10,587,486.

Cash Flow

TuHURA Biosciences, Inc. (NASDAQ:HURA): Cash Flow
2016 -5.14M -16.76K 9.56M
2018 -9.85M -12.64K 9.24M
2020 -7.92M 0 6.60M
2022 -7.50M -36.27K 16.25M
2023 -11.95M -1.29M 2.66M

HURA Cash Flow Statement (2015 – 2023)

2023 2022 2019 2017 2015
Cash at beginning of period
14.25M5.54M3.71M6.58M1.75M
Operating activities
Net income
-29.31M-9.36M-9.12M-11.13M-8.86M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
177.37K373.09K10K24.52K10.28K
Stock-based compensation expense
478.89K218.27K000
Deferred income tax benefit 478.89K218.27K000
Changes in operating assets and liabilities:
Accounts receivable, net
0016.78K37.07K7.44K
Inventories
00000
Accounts payable
00207K295.77K0
Cash generated by operating activities
-11.95M-7.50M-7.92M-9.85M-5.14M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-79.22K-36.27K0-12.64K-16.76K
Acquisitions Net
-1.21M0000
Cash generated by investing activities
-1.29M-36.27K0-12.64K-16.76K
Financing activities
Common Stock Issued
006.63M9.25M9.57M
Payments for dividends
00-8K-8.35K-8.35K
Repurchases of common stock
-24.75K0000
Repayments of term debt
2.68M-350K000
Cash used in financing activities
2.66M16.25M6.60M9.24M9.56M
Net Change In Cash
-10.58M8.70M000
Cash at end of period
3.66M14.25M2.39M5.97M6.15M